ASCO 2021: Abstract Recommendations From Dr. Ari VanderWalde for Melanoma

Posted by & filed under Uncategorized.

Oral Abstract Session: Melanoma/Skin Cancers Sunday, June 6, 2021; 8:00 AM–11:00 AM EDT 9501 Final analysis of overall survival (OS) and relapse-free-survival (RFS) in the intergroup S1404 phase III randomized trial comparing either high-dose interferon (HDI) or ipilimumab to pembrolizumab in patients with high-risk resected melanoma. KF Grossmann, M Othus, SP Patel, et al Take-Home Message The… Read more »

Home

Posted by & filed under Uncategorized.

Patients and Family We understand how overwhelming a cancer diagnosis can be. Our physicians and staff are here to help you and your loved ones navigate through your entire cancer journey, CareSpace Patient Portal Patient Stories New Patient Paperwork Insurance Information What We Treat What Is Cancer? Pay Bill Care Support Services Healthcare Providers From... Read more »

2020 Top Stories in Advanced Melanoma: Drastic Improvement in Melanoma Mortality With Novel Agents

Posted by & filed under Uncategorized.

2020 Top Stories in Advanced Melanoma: Drastic Improvement in Melanoma Mortality With Novel Agents   Written by Ari VanderWalde MD, MPH, FACP   Despite a plethora of interesting findings and results of novel clinical trials in melanoma in 2020, I believe the most important story of the year was actually a small, easy-to-overlook, 3-page report in the American… Read more »